Pancreas transplantation in type 1 diabetes: Hope vs reality

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 4, 2000, Pages 281-286

  Mayes, James T ^a   Dennis, Vincent W ^b   Hoogwerf, Byron J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

CHRONIC KIDNEY FAILURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW;

DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; QUALITY OF LIFE;

EID: 0034170511     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.4.281     Document Type: Review

References (26)

1. National Diabetes Data Group, editors. Diabetes in America. NIH Publication No. 95-1468. Bethesda MD: National Institutes of Health, 1996.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
3. Belzer, FO, Southard JH. Principles of solid organ preservation by cold storage. Transplantation 1988; 45:673-676.
4. Nghiem DD, Beutel WD, Corry RJ. Duodenocystostomy for exocrine pancreatic drainage in experimental and clinical pancreaticoduodenal transplantation. Transplant Proc 1986; 18:1762-1764.
5. Sollinger HW, Knechtle SJ, Reed A, et al. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991; 214:703-711.
6. Sutherland DER, Dunn DL, Goetz FC, et al. A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 1989; 210:274-288.
7. Kuo PC, Johnson LB, Schweitzer EJ, et al. Simultaneous pancreas/kidney transplantation: a comparison of enteric and bladder drainage of exocrine pancreatic secretions. Transplantation 1997; 63:238-243.
8. Kiebert GM, Oosterhout EC, Van Bronswijk H, et al. Quality of life after combined kidney-pancreas or kidney transplantation diabetic patients with end-stage disease. Clin Transplant 1994; 8:239-245.
9. Hathaway DK Abell T, Cardoso S, et al. Improvement in autonomic and gastric function following pancreas-kidney vs kidney-alone transplantation and the correlation with quality of life. Transplantation 1994; 57:816-822.
10. Solders G. Tyden G, Persson A, et al. Improvement of nerve conduction in diabetic neuropathy: a follow-up study 4 years after combined pancreatic and renal transplantation. Diabetes 1992; 41:946-951.
11. Elmer DS, El-Gebely S, Hathaway D, et al. Use of echocardiography to evaluate improvement in cardiac function following pancreas transplantation. J Trans Coordination 1995; 4:77-83.
12. Navarro X. Kennedy WR, Loewenson RB, et al. Influences of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39:802.
13. Fioretto P, Steffes MW, Sutherland DER, et al. Successful pancreas transplantation alone reverses established lesions of diabetic nephropathy in man. Am Soc Nephrol 1997; 8:111A.
14. Gruessner AC, Sutherland DER. Pancreas transplantation in the US and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry. In: Terasaki PI, Cecka MJ, editors. Clinical transplants. Los Angeles: UCLA Tissue typing Laboratory, 1997.
15. Lewis EJ, Hunsicker LG, Bain et al. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329:1456-1462.
16. Port FK, Wolfe RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270:1339-1343.
17. United Network for Organ Sharing (UNOS) 1997 Annual Report: The US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Dept. of Health and Human Services pub: 128-129.
18. Sollinger HW, Odorico JS, Knechtle SJ, et al. Experience with 500 simultaneous pancreas kidney transplants. Ann Surgery 1998; 228:284-296.
19. Gruessner AC, Sutherland DER. Pancreas transplantation in the US and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry. In: Terasaki PI, Cecka MJ, editors. Clinical transplants. Los Angeles: UCLA Tissue typing Laboratory, 1997.
20. Douzdijan V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model. Am J Kidney Dis 1998; 31:794-802.
21. Troppman C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182:285-316.
22. Kendall DM, Robertson RP. Pancreas and islet transplantation. Challenges for the twenty-first century. Endocrinol Metab Clin North Am 1997; 26:611-630.
23. Alejandro R, Lehmann R, Ricordi C, et al. Long-term function (6 years) of islet allografts in type I diabetes. Diabetes 1997; 46:1983-1989.
24. Ricordi C, Tzakis AG, Carroll PB, et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992; 53:407-414.
25. Neward CB, Clark S, BeltrandelRio H, et al. Engineered cell lines for insulin replacement in diabetes: current status and future prospects. Diabetologica 1997; 40 Suppl 2:42-47.
26. De Vos P, De Haan BJ, Van Schilfgaarde R. Upscaling the production of mcroencapsulated pancreatic islets. Biomaterials 1997; 18:1085-1090.